4th Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2009)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform legislation Medicare and Medicaid related issues and prescription drug policy Medicare policy reforms Prescription drug access issues

Lobbyist	Covered position, as disclosed
DONNA MELTZER	—
ANGELA OSTROM	—

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies appropriations for NIH, CDC, HRSA Funding for Lifespan Respite Care Act Funding for epilepsy research and programs Prescription drug access issue appropriations

Lobbyist	Covered position, as disclosed
DONNA MELTZER	—
ANGELA OSTROM	—

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.